Cullinan Therapeutics, Inc.
CGEM$14.43▼ 5.13% 24h
Cullinan Therapeutics, Inc.CGEM$14.43
+$3.25(+29.11%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$873.39M
P/E ratio
—
EPS (diluted)
$-3.69
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-219.88M
Net margin
—
Gross margin
—
Dividends & financials
Cullinan Therapeutics, Inc. (CGEM) reported revenue of $0 and net income of $-219.88M, or $-3.69 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.